GOSS - Gossamer Bio Inc. (GOSS) CEO Faheem Hasnain on Q4 2020 Results - Earnings Call Transcript

Gossamer Bio, Inc. (GOSS) Q4 2020 Earnings Conference Call February 25, 2021 08:30 A.M. ET Company Participants Bryan Giraudo - CFO Faheem Hasnain - Co-Founder, CEO, & Chairman Richard Aranda - SVP, Clinical Development Conference Call Participants Unidentified Analyst - Carter Gould - Barclays Bank Emma Nealon - Cantor Fitzgerald & Co. Olivia Brayer - Bank of America Securities Patrick Trucchio - H.C. Wainwright & Co Unidentified Analyst - SMBC Presentation Operator Ladies and gentlemen, thank you for standing by, and welcome to the Gossamer Bio Q4 Earnings Call. At this time all participants are in a listen-only mode. After the speakers presentation there will be a question-and-answer session. [Operator Instructions]. I would now like to hand the conference over to your speaker today, Bryan Giraudo. Please go ahead, sir. Bryan Giraudo Thank you, operator and thank you all for joining us this morning. I am joined on today's call

For further details see:

Gossamer Bio, Inc. (GOSS) CEO Faheem Hasnain on Q4 2020 Results - Earnings Call Transcript